A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft

After one drop is instilled subjects will complete a comfort assessment at 1, 3, 5, and 10
minutes after drop instillation.

Inclusion Criteria:

Each patient must meet the following criteria to be enrolled in this study:

1. Are male or female at least 18 years of age who are diagnosed with allergic
conjunctivitis.

2. Have allergic ocular symptoms within the last three days.

3. Are willing/able to follow instructions from the study investigator and his/her
staff.

4. Have signed informed consent approved by Institutional Review Board or Independent
Ethics Committee.

Exclusion Criteria:

Patients who meet any of the following criteria will be excluded from the study:

1. Have known hypersensitivity to either BEPREVE™ or LASTACAFT® or to any component of
the test article (including "procedural" medications such as anesthetic and/or
fluorescein drops, dilating drops, etc.).

2. Have active corneal pathology noted in the study eye at the screening visit. Active
corneal pathology is defined as corneal pathology that is non stable, or greater than
mild, or will compromise assessment of the safety or efficacy of treatment.

3. Are pregnant or nursing/lactating.